UK Companies House feature
ADVANZ PHARMA GENERICS (UK) LIMITED
Profile
- Company number
- 02760679
- Status
- Active
- Incorporation
- 1992-10-30
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21200
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on the going concern basis, which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of operations as they fall due. In assessing the ability of the Company to continue as a going concern, the directors have taken account of the profit in 2024 of £1,434, the cumulative profits of £11,811 and the Company's net current assets and net asset position of £11,811 at 31 December 2024. The Company's Intermediate Holding Company, APHL has provided the Company with a letter of support indicating its intention to provide the financial support required for a period of at least 12 months from the date these financial statements are approved. After making enquiries, considering the Company's forecasts and projections and considering the letter of support received from APHL, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, the directors consider it appropriate to prepare these entity financial statements on a going concern basis.”
Significant events
- “On 25 October 2024, the Group, through its wholly owned subsidiary Cidron Aida Finco SaRL, entered into a senior facilities agreement pursuant to which a syndicate of lenders made available a secured term loan at par for the principal amount of €725 million.”
- “On 8 April 2025, the Group successfully completed the refinancing of its existing €650 million 5% senior secured notes due 2028 and £335 million 6.25% senior secured notes due 2028. This refinancing was effected through the issuance of €615 million in 7% senior secured notes due 2031 and £250 million in 9.125% senior secured notes due 2031, together with a new €165 million term loan facility.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 23 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| TMF CORPORATE ADMINISTRATION SERVICES LIMITED | Corporate Secretary | 2022-03-16 | — | — |
| FERRY, Melvin Jeremy, Mr. | Director | 2025-02-06 | Jun 1982 | British |
| STICKLER, Andreas | Director | 2022-01-21 | Feb 1971 | German |
Show 23 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FARLEY, Joe | Secretary | 1998-04-28 | 2004-12-03 |
| MYRANTS, George, Mr. | Secretary | 1993-01-25 | 1998-04-29 |
| SULLY, Robert | Secretary | 2018-10-01 | 2022-03-16 |
| SULLY, Robert James | Secretary | 2011-07-25 | 2016-12-31 |
| VENKATESWARAN, Subramanian | Secretary | 2004-12-03 | 2011-06-24 |
| WILLIAMS, David Richard | Secretary | 2016-12-31 | 2018-10-01 |
| ELK COMPANY SECRETARIES LIMITED | Corporate Nominee Secretary | 1992-10-30 | 1993-01-25 |
| AHMAD, Adeel | Director | 2016-01-08 | 2022-01-31 |
| BEIGHTON, John, Mr. | Director | 2010-09-08 | 2016-12-31 |
| DUNCAN, Graeme Neville | Director | 2018-11-30 | 2022-01-12 |
| DUNCAN, Graeme Neville | Director | 2017-06-19 | 2018-03-08 |
| KAMATH, Vikram Laxman | Director | 2012-10-23 | 2025-02-06 |
| MYRANTS, George, Mr. | Director | 1993-01-25 | 1998-04-29 |
| MYRANTS, Sandra Anne | Director | 1993-01-25 | 1998-04-29 |
| PATEL, Ajay Mafatlal | Director | 2000-01-04 | 2010-08-31 |
| PATEL, Ajit Ramanlal | Director | 1998-04-29 | 2007-07-02 |
| PATEL, Kirti Vinubhai | Director | 1998-04-29 | 2007-12-31 |
| PATEL, Rakesh Vinodrai | Director | 2000-01-04 | 2010-05-19 |
| RAMAN, Anand | Director | 2011-01-26 | 2012-10-23 |
| SCHWALBER, Philipp Theodor | Director | 2010-03-02 | 2012-04-18 |
| STONE, Lisa | Director | 2010-03-02 | 2012-04-18 |
| VAN TIGGELEN, Antonie Pieter | Director | 2013-09-25 | 2016-01-08 |
| ELK (NOMINEES) LIMITED | Corporate Nominee Director | 1992-10-30 | 1993-01-25 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mercury Pharma Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-06-01 | Active |
| The Blackstone Group Inc. | Corporate entity | Shares 25–50%, Voting 25–50% | 2020-03-27 | Ceased 2021-06-01 |
| Mercury Pharma Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2018-08-10 | Ceased 2020-03-27 |
Filing timeline
Last 20 of 180 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-07-21 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-06-30 | AA | accounts | accounts with accounts type full |
| 2025-02-20 | AP01 | officers | appoint person director company with name date |
| 2025-02-19 | TM01 | officers | termination director company with name termination date |
| 2024-09-02 | AA | accounts | accounts with accounts type full |
| 2024-07-31 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-08-17 | PSC05 | persons-with-significant-control | change to a person with significant control |
| 2023-08-03 | AA | accounts | accounts with accounts type full |
| 2023-08-02 | CH01 | officers | change person director company with change date |
| 2023-08-01 | AD01 | address | change registered office address company with date old address new address |
| 2023-07-27 | CH04 | officers | change corporate secretary company with change date |
| 2023-07-26 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-07-21 | CH01 | officers | change person director company with change date |
| 2022-09-30 | AA | accounts | accounts with accounts type full |
| 2022-07-15 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-03-28 | AP04 | officers | appoint corporate secretary company with name date |
| 2022-03-28 | TM02 | officers | termination secretary company with name termination date |
| 2022-02-02 | AP01 | officers | appoint person director company with name date |
| 2022-02-01 | TM01 | officers | termination director company with name termination date |
| 2022-01-26 | TM01 | officers | termination director company with name termination date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory